Inhibition of platelet aggregation in whole blood by dipyridamole and aspirin
- 1 April 1986
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 42 (2), 215-223
- https://doi.org/10.1016/0049-3848(86)90297-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- COMBINING ANTIPLATELET AGENTS: POTENTIATION BETWEEN ASPIRIN AND DIPYRIDAMOLEThe Lancet, 1985
- Serotonin-induced platelet aggregation in whole blood and the effects of ketanserin and mepyramineThrombosis Research, 1985
- PREVENTION OF PRE-ECLAMPSIA BY EARLY ANTIPLATELET THERAPYThe Lancet, 1985
- DRUG-INDUCED INHIBITION OF PLATELET FUNCTION DELAYS PROGRESSION OF PERIPHERAL OCCLUSIVE ARTERIAL DISEASEThe Lancet, 1985
- THE PLATELET IN ASTHMAThe Lancet, 1984
- Pharmacokinetics of oral dipyridamole (Persantine ) and its effect on platelet adenosine uptake in manEuropean Journal of Clinical Pharmacology, 1982
- Prostacyclin in pregnancy.BMJ, 1980
- Pharmacokinetics of DipyridamoleActa Pharmacologica et Toxicologica, 1979
- Activation and inhibition of blood platelet adenylate cyclase by adenosine or by 2-chloroadenosineLife Sciences, 1972
- Influence of a Pyrimidopyrimidine Derivative on Deamination of Adenosine by BloodCirculation Research, 1964